Skip to main content
SpringerLink
Log in

Pharmaceuticals and Personal Care Products in the Environment

  • Conference paper
The Role of Ecological Chemistry in Pollution Research and Sustainable Development

Abstract

Various problems concerning the pharmaceutical and personal care products (PPCPs) in the environment of the Eastern European countries are described. The main classes of PPCPs in the environment, as well as major occurrence pathways and PPCPs fate, are depicted. The influence of specifics of the regional pharmaceutical market, medication consumption culture and pharmaceutical waste disposal techniques on environmental pollution with PPCPs, are discussed. Examples of wrong drugs prescription, drugs misuse, drugs overconsumption, and poor pharmaceutical waste management are presented. The necessity in research and management of PPCPs with emphasize on the local specifics and practices are concluded.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Haling-Sørensen B, Nilesen N, Lanzky P F, et al. (1998) Occurrence, fate and effects of pharmaceutical substances in the environment — a review. Chemosphere 36: 357–393.

    Article  Google Scholar 

  2. Kolpin D A, Furlong E T, Meyer M T, et al. (2002) Pharmaceuticals, hormones, and other wastewater organic contaminants in U.S. streams 1999–2000 — a National reconnaissance. Env Sci Tech 36(6): 1202–1211.

    Article  CAS  Google Scholar 

  3. Jones O A H, Voulvoulis N, Lester J N (2002) Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36(20): 5013–5022.

    Article  CAS  Google Scholar 

  4. US EPA (1997) Method 1694: Pharmaceuticals and personal care products in water, soil, sediment, and biosolids by HPLC/MS/MS. http://www.epa.gov/waterscience/methods/method/ files/1694.pdf. Accessed 23 November 2008.

  5. US EPA (1997) Method 1698: Steroids and hormones in water, soil, sediment, and bio-solids by HRGC/HRMS. http://www.epa.gov/waterscience/methods/method/files/1698.pdf. Accessed 23 November 2008.

  6. Daughton C G (2008) Pharmaceuticals as environmental pollutants: the ramifications for human exposure. In: Heggenhougen K and Quah S (eds.), International Encyclopedia of Public Health, Vol. 5. Academic Press, San Diego: pp. 66–102.

    Chapter  Google Scholar 

  7. Daughton C G (2007). Pharmaceuticals in the environment: sources and their management. Petrovic J and Barcelo D (eds.), Analysis, Fate and Removal of Pharmaceuticals in the Water Cycle, Elsevier Science, Barcelona: pp. 1–58.

    Chapter  Google Scholar 

  8. Anisimova O S, Frolova L V, Chistyakov V V, et al. (1995) Study of metabolism of the antiviral drug arbidol by mass spectrometry, thin-layer and high-performance liquid chro-matography. J Pharm Chem 29(2): 78–82.

    Article  Google Scholar 

  9. Wang Y, Chen X, Li Q, Zhong D (2008) Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry. J Mass Spectrom 43(8): 1099–1110.

    Article  CAS  Google Scholar 

  10. Manchand P S, Cerruti R L, Martin J A, et al. (1990) Synthesis and antiviral activity of metabolites of rimantadine. J Med Chem 33(7): 1992–1995.

    Article  CAS  Google Scholar 

  11. Bolaji O O, Onyeji C O, Ogundaini A O, et al. (1996) Pharmacokinetics and bioavailability of drotaverine in humans. Eur J Drug Metab Pharmacokinet 21(3): 217–221.

    Article  CAS  Google Scholar 

  12. Magyar K, Lengyel M, Knoll J (1978) Absorption, distribution and elimination of drotaverine. Acta Physiol Acad Sci Hun 51(4): 401–411.

    CAS  Google Scholar 

  13. Müssig K, Pfäfflin A, Häring H-U, Schleicher E D (2006) Dipyrone (metamizole) metabolites interfere with HPLC analysis of plasma catecholamines but not with the determination of urinary catecholamines. Clin Chem 52: 1829–1831.

    Article  CAS  Google Scholar 

  14. Vlahov V, Badian M, Verho M, Bacracheva N (1990) Pharmacokinetics of metamizole metabolites in healthy subjects after a single oral dose of metamizole. Eur J Clin Pharmacol 38(1): 61–65.

    Article  CAS  Google Scholar 

  15. Feldmann D F, Zuehlke S, Heberer T (2008) Occurrence, fate and assessment of polar metamizole (dipyrone) residues in hospital and municipal wastewater. Chemosphere 71(9): 1754–1764.

    Article  CAS  Google Scholar 

  16. Bobkov Iu G, Morozov I S, Glozman O M, et al. (1983) Pharmacological characteristics of a new phenyl analog of piracetam – 4-phenylpiracetam [article in Russian]. Biull EkspBiol Med 95(4): 50–53.

    CAS  Google Scholar 

  17. Stratchounski L S, Andreeva I V, Ratchina S A, et al. (2003) The inventory of antibiotics in Russian home medicine cabinets. Clin Infect Dis 37(4): 498–505.

    Article  CAS  Google Scholar 

  18. Olczac A, Grzesiowski P, Hryniewicz W, Haaijer-Ruskamp F M (2006) Self-medication with antibiotics in Poland. Pol Merkur Lekarski 20(116): 151–154.

    Google Scholar 

  19. Sanz E J, Hernandez M A, Ratchina S, et al. (2005) Prescribers' indications for drugs in childhood: a survey of five European countries (Spains, France, Bulgaria, Slovakia and Russia). Acta Paediatr 94(12): 1784–1790.

    Article  Google Scholar 

  20. Zarocostas J (2007) Misuse of prescription drugs could soon exceed that of illicit narcotics, UN panel warns. Br Med J 334(7591): 444.

    Article  Google Scholar 

  21. Marincovic N, Vitale K, Afrik I, Janev Holcer N (2005) Hazardous medical waste management as a public health issue. Arh Hig Rada Toksikol 56(1): 21–32.

    Google Scholar 

  22. Marinkovic N, Vitale K, Holcer N J, Dzakula A, Pavic T (2008) Management of hazardous medical waste in Croatia. Waste Manag 28(6): 1049–1056.

    Article  CAS  Google Scholar 

  23. Osipova T V, Kolpashchikova I F, Smirenskaia L Iu, et al. (2007) Medical waste the problem of handling [article in Russian]. Gig Sanit 2: 15–17.

    Google Scholar 

  24. Stanković A (2008) Report: treatment of medical waste in Nišava and Toplica districts, Serbia. Waste Manag Res 26(3): 309–313.

    Article  Google Scholar 

  25. Moldovan Z (2006) Occurrences of pharmaceutical and personal care products as micropol-lutants in rivers from Romania. Chemosphere 64(11): 1808–1817.

    Article  CAS  Google Scholar 

  26. Moldovan Z, Schmutzer G, Tusa F, et al. (2007) An overview of pharmaceuticals and personal care products contamination along the river Somes watershed, Romania. J Environ Monit 9(9): 986–993.

    Article  CAS  Google Scholar 

  27. Moller P, Paces T, Dulski P, Morteani G (2002) Anthropogenic Gd in surface water, drainage system, and the water supply of the city of Prague, Czech Republic. Environ Sci Tech-nol 36(11): 2387–2394.

    Article  CAS  Google Scholar 

  28. Morteani G, Moller P, Fuganti A, Paces T (2006) Input and fate of anthropogenic estrogens and gadolinium in surface water and sewage plants in the hydrological basin of Prague (Czech Republic). Environ Geochem Health 28(3): 257–264.

    Article  CAS  Google Scholar 

  29. Kasprzyk-Hordern B, Dabrowska A, Vieno N, et al. (2008) Occurrence of acidic pharmaceuticals in the Warta river in Poland. Chem Anal 53(2): 289–303.

    CAS  Google Scholar 

  30. Sajewicz M (2005) Use of densitometric TLC for detection of selected drugs present in river water in south Poland. J Planar Chromatogr — Modern TLC 18(102): 108–111.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Industrial and Ecological Chemistry, State University of Moldova, 60, Al. Mateevici Street, MD-2009, Chisinau, Republic of Moldova

    Veaceslav Boldescu

Authors
  1. Gheorghe Duca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Veaceslav Boldescu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gheorghe Duca .

Editor information

Editors and Affiliations

  1. Institute of Ecological Chemistry and Waste Analysis, Braunschweig University of Technology, Braunschweig, Germany

    Ali Müfit Bahadir

  2. Academy of Sciences of Moldova, Chisinau, Moldova

    Gheorghe Duca

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media B.V.

About this paper

Cite this paper

Duca, G., Boldescu, V. (2009). Pharmaceuticals and Personal Care Products in the Environment. In: Bahadir, A.M., Duca, G. (eds) The Role of Ecological Chemistry in Pollution Research and Sustainable Development. NATO Science for Peace and Security Series C: Environmental Security. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2903-4_3

Download citation

Publish with us

Policies and ethics

Search

Navigation